论文部分内容阅读
目的对米非司酮周期疗法与孕激素治疗围绝经期功能性出血(围绝经期功血)的疗效进行对比研究。方法选取我院2014年1月~2015年1月收治的围绝经期功血患者80例为研究对象,随机分为观察组与对照组,各40例。对照组采用孕激素治疗,观察组采用米非司酮治疗,对比两组患者的治疗疗效及不良反应发生率。结果观察组的经期时间明显短于对照组;观察组治疗后的P与E2与对照组比较;观察组月经正常率明显高于对照组;复发率显著低于对照组,差异有统计学意义(P<0.05)。结论米非司酮治疗围绝经期功血疗效确切,复发率低,有较高的临床应用价值。
Objective To compare the efficacy of mifepristone cycle therapy with progestin in the treatment of perimenopausal functional bleeding (perimenopausal dysfunctional uterine bleeding). Methods Eighty patients with peri-menopausal dysfunctional uterine bleeding who were treated in our hospital from January 2014 to January 2015 were selected and randomly divided into observation group and control group, 40 cases in each group. The control group was treated with progestin, and the observation group was treated with mifepristone, the treatment efficacy and the incidence of adverse reactions were compared between the two groups. Results The observation group had significantly shorter menstrual period than the control group. The P and E2 in the observation group were significantly higher than those in the control group. The normal menstruation rate in the observation group was significantly higher than that in the control group. The recurrence rate was significantly lower than that in the control group P <0.05). Conclusion Mifepristone treatment of climacteric dysfunctional uterine bleeding is effective, low recurrence rate, and has a high clinical value.